PROTEXT MOBILITY, INC.

Highlights ProText Mobility, Inc.

Equities

TXTM

US74371E2046

Market Closed - OTC Markets Other stock markets 03:46:57 2024-07-12 pm EDT			5-day change	1st Jan Change
0.0008 ^USD	-5.88%		0.00%	-52.94%

2022	Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update	CI
2021	ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update	22-11-01	CI
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility	21-10-29	CI
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc.	19-01-18	CI
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc.	18-01-18	CI
Protext Mobility, Inc. to Conduct Human Clinical Trial with Its Product Phytofare Catechin Complex	17-05-04	CI
ProText Mobility, Inc. acquired Cannabis Biosciences Inc. from Plandaí Biotechnology, Inc. for $0.12 million.	17-03-26	CI
Protext Mobility, Inc. Engages in the Development of Pharmaceutical Applications for the Highly Bioavailable Phytofare®	17-03-07	CI
Plandai SA completed the acquisition of ProText Mobility, Inc. in a reverse merger transaction.	16-12-30	CI
Plandai SA agreed to acquire ProText Mobility, Inc. in a reverse merger transaction.	16-12-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer